$YJGJ
YIJIA GROUP CORP.

2024 Q1 Form 10-Q Financial Statement

#000168316824001418 Filed on March 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q2
Revenue $26.10K $3.000K
YoY Change 161.0% -93.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $20.15K $7.390K
YoY Change -41.73% -89.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.15K $7.390K
YoY Change -41.72% -89.71%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $5.948K -$4.390K
YoY Change -124.2% -83.63%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $5.948K -$4.390K
YoY Change -124.2% -83.63%
Net Earnings / Revenue 22.79% -146.33%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 6.079M shares 5.871M shares
Diluted Shares Outstanding 6.079M shares

Balance Sheet

Concept 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $808.4K $8.730K
YoY Change 7242.05% -62.21%
Cash & Equivalents $808.4K $8.728K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables $156.0K $0.00
Total Short-Term Assets $964.4K $8.728K
YoY Change 8656.52% -62.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $964.4K $8.728K
Total Long-Term Assets $0.00 $0.00
Total Assets $964.4K $8.728K
YoY Change 8656.52% -62.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $93.57K $67.94K
YoY Change 42.12% 16.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $93.57K $67.94K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $93.57K $67.94K
YoY Change 42.12% 16.96%
SHAREHOLDERS EQUITY
Retained Earnings -$151.0K -$123.9K
YoY Change 26.3% 24.3%
Common Stock $25.01K $5.871K
YoY Change 326.03% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $870.8K -$59.22K
YoY Change
Total Liabilities & Shareholders Equity $964.4K $8.728K
YoY Change 8656.52% -62.22%

Cashflow Statement

Concept 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income $5.948K -$4.390K
YoY Change -124.2% -83.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$150.6K -$2.290K
YoY Change 434.28% -83.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 958.9K 0.000
YoY Change 23872.75%
NET CHANGE
Cash From Operating Activities -150.6K -2.290K
Cash From Investing Activities
Cash From Financing Activities 958.9K 0.000
Net Change In Cash 808.3K -2.290K
YoY Change -3443.05% -83.44%
FREE CASH FLOW
Cash From Operating Activities -$150.6K -$2.290K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001699709
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-218733
dei Entity Registrant Name
EntityRegistrantName
Yijia Group Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2583762
dei Entity Address Address Line1
EntityAddressAddressLine1
39 E Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 603
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10002
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
869-0279
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25012270 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
808356 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8728 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
156000 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
964356 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
8728 usd
CY2024Q1 us-gaap Assets
Assets
964356 usd
CY2023Q2 us-gaap Assets
Assets
8728 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
50202 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
51843 usd
CY2024Q1 YJGJ Due To Related Parties Current1
DueToRelatedPartiesCurrent1
43372 usd
CY2023Q2 YJGJ Due To Related Parties Current1
DueToRelatedPartiesCurrent1
16100 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
93574 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
67943 usd
CY2024Q1 us-gaap Liabilities
Liabilities
93574 usd
CY2023Q2 us-gaap Liabilities
Liabilities
67943 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25012270 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25012270 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
25012 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5871 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
996734 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58824 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150964 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123910 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
870782 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
964356 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8728 usd
CY2024Q1 us-gaap Revenues
Revenues
26100 usd
CY2023Q1 us-gaap Revenues
Revenues
10000 usd
us-gaap Revenues
Revenues
26100 usd
us-gaap Revenues
Revenues
35000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20152 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34577 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53154 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54842 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
20152 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
34577 usd
us-gaap Operating Expenses
OperatingExpenses
53154 usd
us-gaap Operating Expenses
OperatingExpenses
54842 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5948 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24577 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27054 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19842 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5948 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24577 usd
us-gaap Net Income Loss
NetIncomeLoss
-27054 usd
us-gaap Net Income Loss
NetIncomeLoss
-19842 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6079305 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6079305 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25012270 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25012270 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24247 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-83462 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-8755 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-92217 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
957051 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5948 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
870782 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34988 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2134 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-32854 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
2601 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-30253 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24577 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-54830 usd
us-gaap Net Income Loss
NetIncomeLoss
-27054 usd
us-gaap Net Income Loss
NetIncomeLoss
-19842 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
156000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1641 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3752 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-184695 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16090 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
957051 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
27272 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
984323 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
799628 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-12090 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8728 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23103 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
808356 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11013 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_800_eus-gaap--BasisOfAccounting_z3pdydjTVh29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 – <i><span id="xdx_820_zHB36x6g4qr7">BASIS OF PRESENTATION</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States (“GAAP”), and the instructions to Form 10–Q and Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, the consolidated balance sheet as of April 30, 2023 which has been derived from audited financial statements and these unaudited condensed consolidated financial statements reflect all normal and considered necessary to state fairly the results for the periods presented. The results for the period ended January 31, 2024 are not necessarily indicative of the results to be expected for the entire fiscal year ending April 30, 2024 or for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Management’s Discussion and the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended April 30, 2023, filed with the SEC on May 16, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
us-gaap Net Income Loss
NetIncomeLoss
-27054 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150964 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zAngB9YcIm94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25012270 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25012270 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
150964 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
150964 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
123910 usd
CY2024Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31702 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26021 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31702 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26021 usd
CY2024Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-001418-index-headers.html Edgar Link pending
0001683168-24-001418-index.html Edgar Link pending
0001683168-24-001418.txt Edgar Link pending
0001683168-24-001418-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yijia_ex3101.htm Edgar Link pending
yijia_ex3102.htm Edgar Link pending
yijia_ex3201.htm Edgar Link pending
yijia_ex3202.htm Edgar Link pending
yijia_i10q-013124.htm Edgar Link pending
yjgj-20240131.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
yjgj-20240131_cal.xml Edgar Link unprocessable
yjgj-20240131_def.xml Edgar Link unprocessable
yijia_i10q-013124_htm.xml Edgar Link completed
yjgj-20240131_pre.xml Edgar Link unprocessable
yjgj-20240131_lab.xml Edgar Link unprocessable